Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Polypill Strategy in Secondary Cardiovascular Prevention

by Owen, Ruth , Ojeda-Fernandez, Luisa , Cordero, Alberto , Lozano, Iñigo , Simon, Tabassome , Vivas, David , Vazquez Rodriguez, Jose M. , Rodriguez-Manero, Moises , Marin Ortuño, Francisco , Beghi, Ettore , Sanchez, Pedro L. , Baviera, Marta , Schiele, François , Fuster, Valentin , Alonso Garcia, Angeles , Doehner, Wolfram , Di Fusco, Stefania A. , Quesada, Antonio J. , Linhart, Aleš , Lopez, Nicolas , Bhatt, Deepak L. , Van de Werf, Frans , Colivicchi, Furio , Castellano, Jose M. , Barczi, Gyorgy , Foresta, Andreana , Schoos, Mikkel M. , Roncaglioni, Maria C. , Domingo-Fernández, Alexandra , Ponikowski, Piotr , Perel, Pablo , Proietti, Marco , Bejot, Yannick , Fernandez-Ortiz, Antonio , Ecarnot, Fiona , Kasprzak, Marta , Ibañez, Borja , Andres, Vicente , Collier, Timothy , Pocock, Stuart J. , Meyer, Antje , Lubanda, Jean-Claude , Bueno, Hector , Merkely, Bela , Fernandez Alvira, Juan M. , Fernandez Ferro, Jose

in Angiotensin / Angiotensin-Converting Enzyme Inhibitors - adverse effects / Angiotensin-Converting Enzyme Inhibitors - therapeutic use / Aspirin / Aspirin - adverse effects / Aspirin - therapeutic use / Atorvastatin / Atorvastatin - adverse effects / Atorvastatin - therapeutic use / Blood pressure / Cardiology / Cardiology General / Cardiovascular disease / Cardiovascular diseases / Cardiovascular Diseases - etiology / Cardiovascular Diseases - mortality / Cardiovascular Diseases - prevention & control / Cerebral infarction / Clinical Medicine / Confidence intervals / Coronary Disease / Death / Diabetes / Disease prevention / Drug dosages / Heart attacks / Humans / Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects / Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use / Ischemia / Ischemic Stroke - prevention & control / Myocardial Infarction / Myocardial Infarction - complications / Myocardial Infarction - prevention & control / Myocardial Infarction - therapy / Outpatient-Based Clinical Medicine / Patient compliance / Patients / Platelet Aggregation Inhibitors - adverse effects / Platelet Aggregation Inhibitors - therapeutic use / Polypharmacy / Prevention / Ramipril - adverse effects / Ramipril - therapeutic use / Secondary Prevention - methods / Stroke

2022

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Polypill Strategy in Secondary Cardiovascular Prevention

2022

Confirm

Do you wish to request the book?

Polypill Strategy in Secondary Cardiovascular Prevention

2022

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Polypill Strategy in Secondary Cardiovascular Prevention

Owen, Ruth,

Ojeda-Fernandez, Luisa,

Cordero, Alberto,

Lozano, Iñigo,

Simon, Tabassome,

Vivas, David,

Vazquez Rodriguez, Jose M.,

Rodriguez-Manero, Moises,

Marin Ortuño, Francisco,

Beghi, Ettore,

Sanchez, Pedro L.,

Baviera, Marta,

Schiele, François,

Fuster, Valentin,

Alonso Garcia, Angeles,

Doehner, Wolfram,

Di Fusco, Stefania A.,

Quesada, Antonio J.,

Linhart, Aleš,

Lopez, Nicolas,

Bhatt, Deepak L.,

Van de Werf, Frans,

Colivicchi, Furio,

Castellano, Jose M.,

Barczi, Gyorgy,

Foresta, Andreana,

Schoos, Mikkel M.,

Roncaglioni, Maria C.,

Domingo-Fernández, Alexandra,

Ponikowski, Piotr,

Perel, Pablo,

Proietti, Marco,

Bejot, Yannick,

Fernandez-Ortiz, Antonio,

Ecarnot, Fiona,

Kasprzak, Marta,

Ibañez, Borja,

Andres, Vicente,

Collier, Timothy,

Pocock, Stuart J.,

Meyer, Antje,

Lubanda, Jean-Claude,

Bueno, Hector,

Merkely, Bela,

Fernandez Alvira, Juan M.,

Fernandez Ferro, Jose

2022

Overview

Among patients with recent MI, therapy with a polypill containing aspirin, ramipril, and atorvastatin led to a lower incidence of major adverse cardiovascular events at a median of 3 years than usual care.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Angiotensin

/ Angiotensin-Converting Enzyme Inhibitors - adverse effects

/ Angiotensin-Converting Enzyme Inhibitors - therapeutic use

/ Aspirin

/ Aspirin - adverse effects

/ Aspirin - therapeutic use

/ Atorvastatin